RxDoctor Payments Data

Chiranjiv Virk, MD

Vascular Surgery · Shreveport, LANPI 1285897132

Payments from drug & device makers

What this record shows

20 manufacturers reported payments, led by W. L. Gore & Associates, Inc. at 55.0% of the total. Reporting peaked in 2022 at $2,373 and has fallen 80.7% since, to $459 in 2025.

$6,913in general payments, 2019–2025

Across 72 payments — averaging $96.02 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.

  • W. L. Gore & Associates, Inc.$4K
  • Medtronic$1K
  • Penumbra, Inc.$264
  • Cook Medical LLC$213
  • GE HealthCare$185
  • Inari Medical, Inc.$157
  • plus $1K from 14 others
$18,430in research payments, 2019–2025

Across 7 payments — averaging $2632.84 each. Payments tied to a research study. These frequently flow through the physician to a hospital or research institution rather than to the physician personally.

  • Phraxis, Inc.$11K
  • W. L. Gore & Associates, Inc.$8K

What the payments were for

  • Travel & lodging$3,38949%
  • Food & beverage$3,52451%

Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.

General payments by program year

19
20
21
22
23
24
25

Who reported the general payments

Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.

What the payments were tied to

Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.

How this compares

$6,913 in reported general payments places this provider in the 60th percentile of 65 vascular surgery providers in Louisiana.

See all vascular surgery providers in Louisiana

Medicare billing

Part B allowed, 2024
$65,774
Medicare patients
184
Services billed
388

What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.

Other vascular surgery in Shreveport

See the full list for Louisiana

Where these figures come from

Is this you, or does something look wrong? →